Banque Cantonale Vaudoise Compass Pathways PLC Transaction History

Banque Cantonale Vaudoise

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	BUY	$7.32 - $10.85 $32,940 - $48,825	4,500 Added 300.0%	6,000 $60,000
Q3 2022 Oct 17, 2022	SELL	$10.73 - $20.07 $16,095 - $30,105	-1,500 Reduced 50.0%	1,500 $16,000
Q2 2022 Aug 02, 2022	BUY	$6.76 - $14.18 $13,317 - $27,934	1,970 Added 191.26%	3,000 $32,000
Q1 2022 May 09, 2022	BUY	$11.13 - $23.04 $5,565 - $11,520	500 Added 94.34%	1,030 $13,000
Q4 2021 Feb 14, 2022	BUY	$21.81 - $48.96 $6,543 - $14,688	300 Added 130.43%	530 $12,000
Q3 2021 Oct 29, 2021	BUY	$29.03 - $38.62 $870 - $1,158	30 Added 15.0%	230 $7,000
Q1 2021 May 11, 2021	BUY	$34.75 - $57.5 $6,950 - $11,500	200 New	200 $7,000

151

33.6M

536K

582K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.